Totally (LON:TLY) Receives Under review Rating from Canaccord Genuity Group

Totally (LON:TLY)‘s stock had its “under review” rating reiterated by Canaccord Genuity Group in a report issued on Thursday, MarketBeat Ratings reports.

Totally Stock Performance

LON:TLY opened at GBX 1.50 ($0.02) on Thursday. The firm’s fifty day simple moving average is GBX 3.79 and its 200-day simple moving average is GBX 6.45. The company has a quick ratio of 0.66, a current ratio of 0.50 and a debt-to-equity ratio of 14.73. The stock has a market cap of £2.95 million, a PE ratio of -0.78 and a beta of 0.55. Totally has a fifty-two week low of GBX 1.27 ($0.02) and a fifty-two week high of GBX 11.50 ($0.15).

Insider Buying and Selling at Totally

In other news, insider John McMullan bought 1,300,000 shares of the stock in a transaction on Friday, March 21st. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £52,000 ($68,983.82). Also, insider Simon Stilwell purchased 534,000 shares of the company’s stock in a transaction dated Wednesday, March 26th. The stock was purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,360 ($28,336.43). 13.31% of the stock is currently owned by corporate insiders.

Totally Company Profile

Totally plc, together with its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom and Ireland. It operates through Urgent Care, Elective Care, and Corporate Wellbeing segments. The company provides urgent treatment centres which manages front door to A&E departments; NHS 111, GP out of hours services; and clinical assessment services providing telephonic access to multidisciplinary teams of clinicians, and acute visiting services as part of an integrated care system.